hearing loss therapy (iN Therapeutics/Deargen)

N/A

Report date: 2025/03/20 15:36:29
NME

Base Information

Drug Namehearing loss therapy (iN Therapeutics/Deargen)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHearing Loss
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesiN Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesiN Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsHearing Loss
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A